Page 5,969«..1020..5,9685,9695,9705,971..5,9805,990..»

Stem cell conference grew from bizarre case

Posted: Published on December 4th, 2012

Ten years ago, Bernard Siegel was just another South Florida lawyer handling child custody cases. Then he filed a petition in Broward County Circuit Court to appoint a temporary guardian for "Baby Eve," a landmark 2002 case that exposed the claims of "human cloning" to be a sham. Siegel walked away believing such claims were overshadowing important work. "I realized the damage to science that was taking place," he said.. Today, the 63-year-old is one of the world's leading champions for stem-cell research and the man behind the World Stem Cell Summit this week in West Palm Beach. Scientists as from as far away as Japan, some from Nobel Prize-winning institutes, will be meeting through Wednesday at the Palm Beach Convention Center, the first time the summit is being held in Florida. "Stem cell research has enormous societal benefit to alleviate human suffering," said Siegel, pointing to the research leading to drug discovery and potential cures. Russell Allen, executive director of BioFlorida, the statewide industry group, said he is aware of Siegel's unusual beginnings in the industry, but "he has an international reputation as a bioscience advocate, not just in the stem cell world." Siegel's unexpected journey from the courtroom … Continue reading

Comments Off on Stem cell conference grew from bizarre case

World stem cell event opens in West Palm Beach

Posted: Published on December 4th, 2012

We have permission to take others off the website, http://www.worldstemcellsummit.com/featured-speakers World Stem Cell Summit organizer Bernie Siegel has joined forces with scientists from the University of Miami to host the 1,000 attendees from 34 countries expected at the summit in West Palm Beach this week. Each have made discoveries in stem-cell research that could make a difference for those suffering from diabetes and heart disease. Dr. Joshua Hare, a cardiologist at UM's Miller School of Medicine, has been a pioneer the use of stem cell therapy to repair damaged hearts. Recently, he completed a clinical trial where scarring was reduced by 33 percent in patients who had previous heart attacks. "The No. 1 reason for heart failure is because of cardiac scarring. If you can remove it and replace with new tissue, that's very exciting," he said. Dr. Camillo Ricordi, director of UM's Diabetes Research Institute, developed an experimental procedure that has improved blood glucose control and the quality of life of some Type 1 diabetics. But the procedure involves organ donors. Ultimately, he's seeking a cure that involves "replacing cells in Type 1 diabetics with insulin-producing cells that are in our own body." "I definitely think the cure is … Continue reading

Comments Off on World stem cell event opens in West Palm Beach

NeoStem to Present at Multiple Conferences in December

Posted: Published on December 3rd, 2012

NEW YORK, Dec. 3, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE MKT:NBS) ("NeoStem" or the "Company"), an emerging leader in the fast growing cell therapy market, today announced that the Company and its subsidiary, Progenitor Cell Therapy ("PCT"), will present at multiple conferences in December. World Stem Cell Summit RedChip Small-Cap Equities Virtual Conference Cell Therapy Manufacturing (Informa Life Sciences' 3rd Annual VIC Congress 2012) American Society of Hematology Annual Meeting and Exposition ("ASH") NeoStem's abstract on VSELTM Technology titled "A Lin-CD45-CD34+ Population of Extracellular Vesicles in Human Blood That Mimics Very Small Embryonic-Like Stem Cells (VSELs) by Flow Cytometry" has been selected for publication online in December in conjunction with the ASH Annual Meeting and Exposition, December 8-11, 2012. The abstract will be available at http://bloodjournal.hematologylibrary.org/site/misc/ASH_Meeting_Abstracts_Info.xhtml. About NeoStem, Inc. NeoStem, continues to develop and build on its core capabilities in cell therapy, capitalizing on the paradigm shift occurring in medicine. We anticipate that cell therapy will have a significant role in the fight against chronic disease and in lessening the economic burden that these diseases pose to modern society. We are emerging as a technology and market leading company in this fast developing cell therapy industry. Our multi-faceted business … Continue reading

Comments Off on NeoStem to Present at Multiple Conferences in December

Autologous Cell Therapy Market expected to reach $2.2 billion by 2017, growing at a CAGR of 21% : MarketsandMarkets

Posted: Published on December 3rd, 2012

Autologous Cell Therapy Market reserach report gives a detailed analysis about state of the art of both autologous stem cell and non-stem cell treatments. It includes the current advances and applications of the technology and trends in terms of market size and growth of autologous cellular therapies in medical treatments globally. (PRWEB) November 30, 2012 Browse ACT market research data tables/figures spread through 111 slides and in-depth TOC on Autologous Cell Therapy (ACT) Market (2012 - 2017). http://www.marketsandmarkets.com/Market-Reports/autologous-cell-therapy-market-837.html Early buyers will receive 10% customization on reports. There is a wide market potential and favorable landscape for adoption across many geographical locations of the world. During the forecast period, these technologies are expected to revolutionize the area of bio-pharma and personalized medicine. High incidence and lack of effective treatment for several diseases will drive the ACT technology in developed and developing nations. Investment activities, for past five years are actively held in research and developments, attracting interests of cell therapy industry firms, medical centers and academic institutions. ACT potential can be demonstrated by mergers, collaborations, acquisitions and partnerships that happened actively between the ACT technology developing companies in past three years. Development of sophisticated automation devices for cell expansion and culture … Continue reading

Posted in Stem Cell Treatments | Comments Off on Autologous Cell Therapy Market expected to reach $2.2 billion by 2017, growing at a CAGR of 21% : MarketsandMarkets

Advanced Cell Technology to Participate on Panels and Host Experts Luncheon at 2012 World Stem Cell Summit

Posted: Published on December 3rd, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Advanced Cell Technology, Inc. (ACT; OTCBB: ACTC or the Company), a leader in the field of regenerative medicine, announced today that the company is a sponsor of the 2012 World Stem Cell Summit , Dec. 3-5 at the Palm Beach County Convention Center in West Palm Beach, Florida. The Company will host an Experts Luncheon and chairman and CEO Gary Rabin and director of business development Matthew Vincent, Ph.D., will also serve on panels at the event. On Monday, Dec. 3, Dr. Vincent will host a Conversation with Experts Luncheon at which he will meet with conference attendees to discuss the Companys programs and the future of regenerative medicine and stem cell therapies. Also on Monday, Dec. 3, at 4:00 p.m. EST Dr. Vincent will serve on a panel titled Understanding the Legal and Policy Challenges to Stem Cell Research and on Tuesday, Dec. 4, at 10:30 a.m. EST Mr. Rabin will be part of a Clinical Trial Update session, providing an update on the Companys three ongoing human clinical trials for dry age-related macular degeneration (dry AMD) and Stargardts disease using human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells. The full conference agenda is … Continue reading

Posted in Stem Cell Human Trials | Comments Off on Advanced Cell Technology to Participate on Panels and Host Experts Luncheon at 2012 World Stem Cell Summit

VistaGen Therapeutics Becomes Member of Centre for Commercialization of Regenerative Medicine (CCRM) Consortium

Posted: Published on December 3rd, 2012

SOUTH SAN FRANCISCO, CA--(Marketwire - Dec 3, 2012) - VistaGen Therapeutics, Inc. ( OTCBB : VSTA ), a biotechnology company applying stem cell technology for drug rescue, predictive toxicology and drug metabolism screening, has formalized its membership in the Toronto-based Centre for Commercialization of Regenerative Medicine's (CCRM) Industry Consortium. "VistaGen's membership reflects our strong association with CCRM and its core programs and objectives, both directly and through our strategic relationships with Dr. Gordon Keller and the University Health Network (UHN).Our long-term sponsored research agreement with Dr. Keller, UHN and UHN's McEwen Centre for Regenerative Medicine offers both a solid foundation and unique opportunities for expanding the commercial applications of our Human Clinical Trials in a Test Tube platform by building multi-party collaborations with CCRM and members of its Industry Consortium," says Shawn Singh, VistaGen CEO. "These collaborations have the potential to transform medicine and accelerate significant advances in human health and wellness that stem cell technologies and regenerative medicine promise." "Even before VistaGen joined CCRM's Industry Consortium it was active in the Toronto regenerative medicine community and advising us as we prepared to launch in 2011," explains Dr. Michael May, CEO of the Centre for Commercialization of Regenerative Medicine. "I'm … Continue reading

Comments Off on VistaGen Therapeutics Becomes Member of Centre for Commercialization of Regenerative Medicine (CCRM) Consortium

Stem cell-derived dopaminergic neurons rescue motor defects in Parkinsonian monkeys

Posted: Published on December 3rd, 2012

ScienceDaily (Dec. 3, 2012) Researchers have derived dopaminergic neurons from bone marrow stem cells in monkeys. Parkinson's disease is a degenerative disorder of the central nervous system that is characterized by tremors, rigidity, slowness of movement, and difficulty walking. It is caused by loss of the neurons that produce the neurotransmitter dopamine (known as dopaminergic neurons). One of the primary goals in Parkinson's disease research is to develop a replacement for dopaminergic neurons. In a new study, researchers led by Takuya Hayashi at the RIKEN Center for Molecular Imaging Science in Kobe, Japan, derived dopaminergic neurons from bone marrow stem cells in monkeys. The cells were retrieved during a standard bone marrow aspiration and then treated with growth factors that directed the stem cells to become dopaminergic neurons. The monkeys that donated the stem cells were treated with a chemical to induce Parkinson's disease and then received a transplant of the new dopaminergic neurons that had been derived from their own bone marrow stem cells. Monkeys that received the transplant showed significant improvement in motor defects. This study demonstrates that dopaminergic neurons derived from adult bone marrow stem cells can be safely used to improve motor function in Parkinson's disease … Continue reading

Comments Off on Stem cell-derived dopaminergic neurons rescue motor defects in Parkinsonian monkeys

UA professor furthers stem cell research

Posted: Published on December 3rd, 2012

By SARAH-JAYNE SIMON Published December 2, 2012 at 9:46pm Updated December 2, 2012 at 9:46pm A UA professor has been recognized for his work as a pioneer in stem cell banking. David Harris, professor of immunobiology, was awarded the Arizona BioIndustry Association 2012 award for 20 Years of Discovery and Innovation. Harris recognition is the culmination of decades of work in the field of stem cell research. Harris came to the UA 23 years ago from the University of North Carolina and said he was interested in improving the bone marrow transplant process. As a result, he began to use a process called cord blood banking. In 1991, Harris became the first person to bank stem cells for future use, which includes saving them for future treatments. Its nice to end up being recognized for something that you have worked on for a long time, Harris said. Taking something and making it important for everyday life for people to improve their life is amazing. From starting with animal models and moving to human beings is huge; its nice to see it go from one point to another. Harris said he banked stem cells for future use by preserving his first … Continue reading

Comments Off on UA professor furthers stem cell research

Seeing results from stem cell treatment

Posted: Published on December 3rd, 2012

Christine Wood/Photo Alison Johnstone kisses and hugs her grandson Rylan who is showing signs of improvement after receiving stem cell treatments in China last month. Christine Wood/Staff Writer Since returning home from having stem cell treatments in China last month, five-year-old Rylan Johnstone has taken his first unaided steps, given his first hug, spoken his first complete sentence and shown his first reaction to light much to the delight of his family. We are absolutely overjoyed with the changes weve noticed already, said Rylans grandma Alison. Even if thats all that happens, it was definitely worth it to go, but I think there are more changes to come. The family spent nearly a year fundraising more than $34,000 for the trip to China to have the stem cell treatments done in the hope that Rylan, who is blind and autistic, would gain some sight and mobility and benefit from reduced autism symptoms. It seems much of that wish list has come true just weeks after returning from China, and the stem cells will keep working, Alison said. The stem cell injections in his eyes should keep working for at least six months, she said, noting one report from a parent … Continue reading

Comments Off on Seeing results from stem cell treatment

Chinese men fear having no money, women fret about ageing

Posted: Published on December 3rd, 2012

Beijing, Dec 3 (IANS) So, what are the Chinese afraid of? While men fear having no money, women worry about getting old, says an online poll. Baidu Zhidao website has published a list of the "Things that the Chinese people are most afraid of", sparking heated debate, reported People's Daily. Statistics show that nearly 2.9 million answers given by male registered users are about the fear of having no money, while over 2.7 million answers by women focus on worries about getting old. The causes of worry for men also include frustration in their careers. They are afraid of losing, or being compared with others. Women generally worry about emotional problems. They are afraid of their man having an affair and seem to lack a sense of security. When it comes to physical appearances, men are most afraid of becoming bald, having a beer belly and impotency. Women are afraid of their face becoming wrinkled, getting sagging breasts and a thicker waist, the media report said. Many Internet users agreed with the conclusion that men fear having no money while women hate getting old. However, there were others who disagreed. "Material wealth is not the only criterion to measure whether … Continue reading

Posted in Impotency | Comments Off on Chinese men fear having no money, women fret about ageing

Page 5,969«..1020..5,9685,9695,9705,971..5,9805,990..»